Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC grew its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 131,246.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 386,158 shares of the medical instruments supplier's stock after purchasing an additional 385,864 shares during the period. GAMMA Investing LLC owned approximately 1.85% of Mettler-Toledo International worth $456,018,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Versant Capital Management Inc boosted its position in shares of Mettler-Toledo International by 291.8% during the 1st quarter. Versant Capital Management Inc now owns 333 shares of the medical instruments supplier's stock worth $393,000 after purchasing an additional 248 shares in the last quarter. Siemens Fonds Invest GmbH boosted its position in shares of Mettler-Toledo International by 997.8% during the 4th quarter. Siemens Fonds Invest GmbH now owns 2,536 shares of the medical instruments supplier's stock worth $3,103,000 after purchasing an additional 2,305 shares in the last quarter. Menard Financial Group LLC purchased a new stake in shares of Mettler-Toledo International during the 4th quarter worth $67,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Mettler-Toledo International during the 4th quarter worth $45,049,000. Finally, Mackenzie Financial Corp boosted its position in shares of Mettler-Toledo International by 17.5% in the 4th quarter. Mackenzie Financial Corp now owns 2,268 shares of the medical instruments supplier's stock worth $2,775,000 after buying an additional 338 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MTD has been the topic of several recent research reports. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price objective for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Evercore ISI boosted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $1,302.11.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director now owns 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Trading Up 2.2%

Shares of NYSE MTD traded up $24.98 on Tuesday, reaching $1,166.11. 214,479 shares of the company traded hands, compared to its average volume of 150,709. Mettler-Toledo International Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The company has a 50 day moving average of $1,092.81 and a 200 day moving average of $1,205.23. The stock has a market capitalization of $24.24 billion, a PE ratio of 28.77, a P/E/G ratio of 3.30 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the prior year, the company posted $8.89 EPS. The company's quarterly revenue was down 4.6% compared to the same quarter last year. As a group, research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.